If you are wondering whether Praxis Precision Medicines is still priced attractively after its big run, this article will walk through what that current share price could imply about the company. The ...

Praxis Precision Medicines targets neurological and psychiatric disorders with a pipeline of precision therapies for CNS ...

Praxis Precision Medicines remains a Hold as valuation now reflects high expectations for ulixacaltamide and its epilepsy pipeline. Ulixacaltamide’s Essential3 data appear statistically robust, but a ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision ...

Praxis Precision Medicines will present late-stage epilepsy and movement disorder data at the AAN 2025 Annual Meeting in San Diego. Praxis Precision Medicines, Inc. announced its participation in the ...

Explore Praxis Funds Praxis Impact Large Cap Value ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRXV.

Praxis Precision Medicines, Inc. announced significant progress in its clinical pipeline, projecting six major study readouts across four programs in the next 12 months. The company plans to initiate ...

RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency from baseline, with 22% at 100% seizure reduction in ...

Dryden Brown wants Praxis to be a crypto-city for tech bros and tastemakers. Just don’t ask for details. Praxis is part of a nebulous group of right-wing influencers who celebrate antiquity, ...